The following is my best effort to make pharmacology sound exciting to the layperson...because I have zero life and way too much free time. If you don’t like thinking very hard, then you should probably move to the next post. If anyone actually reads this to completion, please give yourself a firm hug and say, “I’m amazing!”
I’ve been having a ton of anxiety lately and I’m convinced it has to do with one of my medications. My usual pharmacy was out of my usual brand of Ritalin this month and so I was forced to go elsewhere and acquire pills from a different manufacturer.
“But Knotorious, why would this cause you to have a different experience? Aren’t pharmaceuticals regulated and held to the highest of standards with regard to continuity of synthesis, production and strength?”
Well, sort of. The reality is that any given drug of the same type, per FDA regulations, is allowed to differ in strength and synthesis by as much as 20%. For example, you might have version A of Ritalin, made by manufacturer A, at a strength of 10mg which actually contains 10mg of the active ingredient.
But then one day you are forced to try version B of Ritalin, by manufacturer B, and it may either have as much as 20% less of the active ingredient OR it might have a synthesis (production method) which has a up to 20% deviation relative to the FDA standards. Inversely, you might find that a different drug has up to 20% more active ingredient and/or alteration of synthesis. One can see how 20% differences in each drug might either dramatically improve or worsen a psychiatric, or even physiological, condition.
In my case, the drug that I have received this time around does not appear to be less potent, however, it does appear to have been manufactured via a different synthesis. Ritalin (methylphenidate) is what is known as an NDRI, or norepinephrine and dopamine reuptake inhibitor. It increases concentrations of both catecholamines via prevention of either’s ability to reuptake (reabsorb) into the presynaptic cleft of the brain. In other words, it doesn’t generate those neurotransmitters, it potentiates them.
The Ritalin I received, with its different and inferior production method, resulted in a mixture of the drug that has a much higher concentration of the levorotary salt (which increases concentrations of norepinephrine) versus the dextrorotary salt (which increases dopamine concentrations).
It is well established that norepinephrine and the levorotary salt predominantly influences the PNS (peripheral nervous system), whereas dopamine and the dextrorotatory salt mostly influences the CNS (central nervous system). It is also known that PNS stimulation, when in excess, can lead to restlessness, agitation, tachycardia, and anxiety, etc. Most psychiatric drugs are designed to potentiate effects in the CNS because the effects are significantly more therapeutic and tolerable.
While norepinephrine receptors are important targets for drugs which treat ADHD, it is dopamine which is considered mostly responsible for the paradoxical calming effect of this particular stimulant, a member of the cathinone family.
In summation, I believe that the Ritalin I recently received has been produced differently than the variant I am used to. As a result, I am experiencing unusual anxiety due to believed higher concentrations of the levorotary enantiomer of methylphenidate, resulting in a sub-therapeutic product with an excess of noradrenergic activity.
Thanks for letting me be myself! Now let’s end this message with a "transparent rickroll”…
EDIT: If my f*cking Ritalin was working normally, I'd be too focused on actually accomplishing something instead of writing excruciatingly lengthy messages.